ISSN 2035-8164
Vol. 4, Issue 3, 2012September 04, 2012 EDT
The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta
The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta
Articles in Vol. 4, Issue 3, 2012
Vol. 4, Issue 3, 2012
- 2012 Austria Swiss German fellowship: making new friendsRajarshi Bhattacharya
- An unusual case of bipolar segmental clavicle fractureKarishma SethiSimon D.S. NewmanRajarshi Bhattacharya
- Surgical management of idiopathic torticollis secondary to a fibrotic bandChristopher David JonesAmir NakhdjevaniSurjit Lidder
- Injury rates of the German Women’s American Football National Team from 2009 to 2011Marco EzechieliStephan BergerChristian-Heige SiebertOliver Miltner
- The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfectaIngmar IpachTorsten KlubaPetra WolfBertram PontzFalk Mittag
- Microsection analysis of cortical form-fit of a custom femoral component in total hip arthroplasty: an in vitro studyUlf Gunther LeichtleCarmen Ina LeichtleFranz Martini
1.
Ipach I, Kluba T, Wolf P, Pontz B, Mittag F. The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta. Orthopedic Reviews. 2012;4(3):e29-e29. doi:10.4081/or.2012.e29